209 Results for "

Modifier

" in MedChemExpress (MCE) Product Catalog:
Products (209)

209 Results for "Modifier" in MCE Product Catalog:

67
67 Publications Verification
Art. -Nr.: HY-B0180
CAS. Nr.: 99011-02-6
Synonyms: R 837
Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
67
67 Publications Verification
Art. -Nr.: HY-B0180A
CAS. Nr.: 99011-78-6
Synonyms: R 837 hydrochloride
Imiquimod hydrochloride (R 837 hydrochloride), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod hydrochloride exhibits antiviral and antitumor effects in vivo. Imiquimod hydrochloride can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
67
67 Publications Verification
Art. -Nr.: HY-B0180B
CAS. Nr.: 896106-16-4
Imiquimod maleate (R 837 maleate), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod maleate exhibits antiviral and antitumor effects in vivo. Imiquimod maleate can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-109101
CAS. Nr.: 1825352-65-5
Reinheit:  99.58%
Synonyms: RG7916; RO7034067
Target:  

DNA/RNA Synthesis

Forschungsgebiete:  

Neurological Disease

Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-101792
CAS. Nr.: 1449598-06-4
Reinheit:  99.88%
Synonyms: RO6885247
Target:  

DNA/RNA Synthesis

Forschungsgebiete:  

Others

RG7800 is a SMN2 splicing modifier. RG7800 has the potential for spinal muscular atrophy treatment.
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-122575
CAS. Nr.: 4431-00-9
Reinheit:  ≥92.0%
Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively . Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase . Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis . Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway . Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 μM . Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 µM .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-W011950
CAS. Nr.: 52417-22-8
Target:  

DNA/RNA Synthesis

Forschungsgebiete:  

Others

Acridin-9-amine (9-Aminoacridine) hydrochloride hydrate is a mutagen and DNA modifier. Acridin-9-amine hydrochloride hydrate induces mutagenic lesions during DNA replication .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-10913A
CAS. Nr.: 943133-81-1
Reinheit:  99.49%
Synonyms: GAP-134 Hydrochloride; ZP 1609 Hydrochloride
Target:  

Gap Junction Protein

Forschungsgebiete:  

Cardiovascular Disease

Danegaptide Hydrochloride (GAP-134 Hydrochloride) is a potent, selective and orally active gap-junction modifier with an antiarrhythmic effect .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-18593
CAS. Nr.: 104723-60-6
Synonyms: 6-O-alpha-D-Maltosyl-beta-cyclodextrin
Mal-β-CD is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol.
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P80351
Synonyms: DAP1 antibody; GAP modifying protein 1 antibody; GMP 1 antibody; OFC10 antibody; PIC 1 antibody; PIC1 antibody; SENP2 antibody; Sentrin 1 antibody; Sentrin antibody; Small ubiquitin related Modifier 1 antibody; Small ubiquitin-like Modifier 1 antibody; Small ubiquitin-related Modifier 1 antibody; SMT3 antibody; SMT3 homolog 3 antibody; SMT3 suppressor of mif two 3 homolog 1 antibody; SMT3, yeast, homolog 3 antibody; Smt3C antibody; SMT3H3 antibody; SUMO-1 antibody; SUMO1 antibody; SUMO1_HUMAN antibody; Ubiquitin homology domain protein PIC1 antibody; Ubiquitin Like 1 antibody; Ubiquitin like protein SMT3C antibody; Ubiquitin like protein UBL1 antibody; Ubiquitin-homology domain protein PIC1 antibody; Ubiquitin-like protein SMT3C antibody; Ubiquitin-like protein UBL1 antibody; UBL 1 antibody; UBL1 antibody

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, IP, FC, ChIP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P74485
Reinheit:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: UBA1; Ubiquitin Like Modifier Activating Enzyme 1; A1S9T; UBE1; GXP1; Ubiquitin-Like Modifier-Activating Enzyme 1; Ubiquitin-Activating Enzyme E1; CFAP124; UBE1X; POC20; Ubiquitin-Activating Enzyme E1 (A1S9T And BN75 Temperature Sensitivity Complementing)
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-13619
CAS. Nr.: 131179-95-8
Reinheit:  99.94%
Synonyms: RSR13
Target:  

Hemoglobin

Forschungsgebiete:  

Infection Cancer

Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-13619A
CAS. Nr.: 170787-99-2
Reinheit:  99.90%
Synonyms: RSR13 sodium
Target:  

Hemoglobin

Forschungsgebiete:  

Infection Cancer

Efaproxiral (RSR13) sodium is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral sodium decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-153182
CAS. Nr.: 1628799-51-8
Reinheit:  99.37%
Target:  

Drug Derivative

Forschungsgebiete:  

Cardiovascular Disease

GBT1118 is a potent and orally active allosteric modifier of hemoglobin oxygen affinity. GBT1118 increases tolerance to severe hypoxia .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B1008A
CAS. Nr.: 138-84-1
Synonyms: PABA potassium; p-Aminobenzoic acid potassium
4-Aminobenzoic acid (PABA) potassium is a modifier of catecholamine oxidation reactions. 4-Aminobenzoic acid potassium is promising for research of Parkinson's disease and hypertension .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-109101S
Reinheit:  98.88%
Risdiplam-d4 is deuterium labeled Risdiplam. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P81832
Synonyms: C13orf20; BM-002; UFM1; Ubiquitin-fold Modifier 1

Host:  

Rabbit

Application:  

WB, IHC-P, IP

Reactivity:  

Human, Mouse

loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P81309
Synonyms: SMT3B; SMT3H2; SUMO2; Small ubiquitin-related Modifier 2; SUMO-2; HSMT3; SMT3 homolog 2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3B; Smt3B

Host:  

Mouse

Application:  

WB

Reactivity:  

Human

loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-117570
CAS. Nr.: 2226201-97-2
Reinheit:  98.03%
Target:  

PDI

Forschungsgebiete:  

Neurological Disease

KSC-34, a covalent modifier of protein disulfide isomerase A1 (PDIA1), is also a selective and potent a-site inhibitor of PDIA1 with an IC50 of 3.5 μM. KSC-34 displays a 30-fold selectivity for a domain over a′ domain and displays high selectivity for PDIA1 in complex proteomes with minimal engagement of other members of the PDI family . KSC-34 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-15929
CAS. Nr.: 14348-40-4
Synonyms: 2,4,6-Tribromo-3-hydroxybenzoic acid
TBHBA (2,4,6-Tribromo-3-hydroxybenzoic acid) is a chemical colorimetric agent and nanomaterial surface modifier. TBHBA can react with some oxidants (such as H2O2) to generate high-absorbance quinoneimine dyes, which enhance the sensitivity of HDL cholesterol enzymatic determination. TBHBA can be used as a bromine-containing coupling agent to modify the surface of silica nanoparticles through esterification reaction. Thereby, organic flame retardant groups are introduced to improve the thermal stability and flame retardant properties of nanocomposites. TBHBA can be used in clinical biochemical testing (such as serum lipoprotein analysis) and the preparation of flame-retardant polymer nanocomposites .
loading...
    loading...